Literature DB >> 8901372

Validity and reliability of the Spanish version of the Psychological General Well-Being Index.

X Badia1, F Gutiérrez, I Wiklund, J Alonso.   

Abstract

The Psychological General Well-Being Index (PGWBI) was adapted for use in Spain. The American version was translated and back-translated independently by three bilinguals and the comprehensibility of a consensuated version was tested in a pilot study. The construct validity and internal consistency of the questionnaire were tested in 104 patients (52 high blood pressure patients attending a primary health care centre and 52 end-stage renal disease patients undergoing hemodialysis). Concurrently to the PGWBI, patients were administered the General Health Questionnaire (GHQ-12) and three psychosocial categories of the Sickness Impact Profile (SIP-PD). Patients in the dialysis group were administered the PGWBI on two occasions, two weeks apart. The PGWBI was moderately to highly correlated with the GHQ-12 (r = -0.71) and with the SIP-PD (r = -0.69). Overall internal consistency as measured by Cronbach's alpha coefficient was 0.94. By dimensions, PGWBI alpha coefficients ranged from 0.56 (Self-control) to 0.88 (Anxiety). No differences were found in mean PGWBI scores between the two groups of patients studied. Two-week test-retest intraclass correlation coefficient was 0.76. The similarity of the operating characteristics supports the contention that the Spanish and American versions of the PGWBI are conceptually equivalent. More research is needed on the reliability and responsiveness of the different dimensions of the questionnaire. Our results suggest that only global scores should be used when making individual comparisons.

Entities:  

Mesh:

Year:  1996        PMID: 8901372     DOI: 10.1007/bf00435974

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  21 in total

1.  Quality of life on antihypertensive drug therapy: scientific end-point or marketing exercise?

Authors:  P Hjemdahl; I K Wiklund
Journal:  J Hypertens       Date:  1992-12       Impact factor: 4.844

2.  Quality of life assessment before and after growth hormone treatment in adults with growth hormone deficiency.

Authors:  G A McGauley
Journal:  Acta Paediatr Scand Suppl       Date:  1989

3.  Evaluation of quality of life in clinical trials. Selecting quality-of-life measures.

Authors:  I Wiklund; J Karlberg
Journal:  Control Clin Trials       Date:  1991-08

4.  Antihypertensive therapy and quality of life: a comparison of atenolol, captopril, enalapril and propranolol.

Authors:  S S Steiner; A J Friedhoff; B L Wilson; J R Wecker; J P Santo
Journal:  J Hum Hypertens       Date:  1990-06       Impact factor: 3.012

5.  Overview of adult health measures fielded in Rand's health insurance study.

Authors:  R H Brook; J E Ware; A Davies-Avery; A L Stewart; C A Donald; W H Rogers; K N Williams; S A Johnston
Journal:  Med Care       Date:  1979-07       Impact factor: 2.983

6.  [Adaptation of a measure of dysfunction-related illness: the Spanish version of Sickness Impact Profile].

Authors:  X Badia; J Alonso
Journal:  Med Clin (Barc)       Date:  1994-01-29       Impact factor: 1.725

7.  Hypertensive black men and women. Quality of life and effects of antihypertensive medications. Black Hypertension Quality of Life Multicenter Trial Group.

Authors:  S H Croog; B W Kong; S Levine; M R Weir; R M Baume; E Saunders
Journal:  Arch Intern Med       Date:  1990-08

8.  The effects of antihypertensive therapy on the quality of life.

Authors:  S H Croog; S Levine; M A Testa; B Brown; C J Bulpitt; C D Jenkins; G L Klerman; G H Williams
Journal:  N Engl J Med       Date:  1986-06-26       Impact factor: 91.245

9.  Quality of life with three antihypertensive treatments. Cilazapril, atenolol, nifedipine.

Authors:  A E Fletcher; C J Bulpitt; D M Chase; W C Collins; C D Furberg; T K Goggin; A J Hewett; A M Neiss
Journal:  Hypertension       Date:  1992-06       Impact factor: 10.190

10.  Validity of the scaled version of the General Health Questionnaire (GHQ-28) in a Spanish population.

Authors:  A Lobo; M J Pérez-Echeverría; J Artal
Journal:  Psychol Med       Date:  1986-02       Impact factor: 7.723

View more
  8 in total

Review 1.  Health related quality of life in inflammatory bowel disease: the impact of surgical therapy.

Authors:  Konstantin Umanskiy; Alessandro Fichera
Journal:  World J Gastroenterol       Date:  2010-10-28       Impact factor: 5.742

2.  [Assessment of functional capacity, psychological well-being and mental health in primary care].

Authors:  Abilio Reig-Ferrer; Julio Cabrero-García; Luis Lizán Tudela
Journal:  Aten Primaria       Date:  2009-05-09       Impact factor: 1.137

3.  Measuring outcomes in allergic rhinitis: psychometric characteristics of a Spanish version of the congestion quantifier seven-item test (CQ7).

Authors:  Antonio Valero; Joaquim Mullol; Michael Herdman; Maria-José Rosales
Journal:  Health Qual Life Outcomes       Date:  2011-03-10       Impact factor: 3.186

4.  Heavy Menstrual Bleeding-Visual Analog Scale, an Easy-to-Use Tool for Excessive Menstrual Blood Loss That Interferes with Quality-of-Life Screening in Clinical Practice.

Authors:  Josep Perelló; Pau Pujol; Montse Pérez; Maite Artés; Joaquim Calaf
Journal:  Womens Health Rep (New Rochelle)       Date:  2022-05-09

5.  Psychometric evaluation of the Spanish version of the MPI-SCI.

Authors:  M D Soler; Y Cruz-Almeida; J Saurí; E G Widerström-Noga
Journal:  Spinal Cord       Date:  2013-04-23       Impact factor: 2.772

6.  A combination of ascorbic acid and α-tocopherol to test the effectiveness and safety in the fragile X syndrome: study protocol for a phase II, randomized, placebo-controlled trial.

Authors:  Yolanda de Diego-Otero; Rocio Calvo-Medina; Carolina Quintero-Navarro; Lourdes Sánchez-Salido; Francisco García-Guirado; Ignacio del Arco-Herrera; Isabel Fernández-Carvajal; Teresa Ferrando-Lucas; Rafaela Caballero-Andaluz; Lucia Pérez-Costillas
Journal:  Trials       Date:  2014-09-03       Impact factor: 2.279

7.  A motivational interview program for cardiac rehabilitation after acute myocardial infarction: study protocol of a randomized controlled trial in primary healthcare.

Authors:  Rocío Rodríguez-Romero; Carles Falces; Belchin Kostov; Noemí García-Planas; Esther Blat-Guimerà; María C Alvira-Balada; Mireia López-Poyato; María L Benito-Serrano; Ingrid Vidiella-Piñol; Juan J Zamora-Sánchez; Marta Benet; Manuel V Garnacho-Castaño; Susana Santos-Ruiz; Rosalia Santesmases-Masana; Silvia Roura-Rovira; Jaume Benavent-Areu; Antoni Sisó-Almirall; Luis González-de Paz
Journal:  BMC Prim Care       Date:  2022-05-06

8.  New therapeutic approach to Tourette Syndrome in children based on a randomized placebo-controlled double-blind phase IV study of the effectiveness and safety of magnesium and vitamin B6.

Authors:  Rafael Garcia-Lopez; Emilio Perea-Milla; Cesar Ruiz Garcia; Francisco Rivas-Ruiz; Julio Romero-Gonzalez; Jose L Moreno; Vicente Faus; Guadalupe del Castillo Aguas; Juan C Ramos Diaz
Journal:  Trials       Date:  2009-03-10       Impact factor: 2.279

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.